__

Investor Information

PROTEONOMIX, INC. (OTC.BB: PROT) is a biotechnology company engaged in the discovery and development of stem cell therapeutic and cosmeceutical products. We are developing pre clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. Our discoveries involve non embryonic stem cell treatments.

We have developed sufficient technology for patent applications including a medium and a scaffolding for enhancing the growth of stem cells, a growth platform for stem cells, a unique cord blood banking cryopreservation bag and cosmetic products utilizing a secreted matrix derived from stem cells. We have developed some of our intellectual property utilizing our management and advisory team in conjunction with third party universities and research centers.

We have concentrated on our cosmeceutical treatments based on our licensed technology which we believe will be our lead revenue product in the market. We have completed the development of our cosmeceutical products and we anticipate sales to begin in 2010.

Proteonomix, Inc. (PROT) Plans European Investor Road Show

-Michael Cohen, Chairman and CEO, to Visit Several European Cities to Discuss Company’s Growth Plan and Future Outlook With Investors

PROTEONOMIX, INC. (OTC.BB:PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced last week that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.

Scheduled for early October, Mr. Cohen will discuss with sophisticated investors the recent contract to establish a joint venture with a group of investors that will establish a new stem cell treatment and research facility in the United Arab Emirates (U.A.E.). In addition, Mr. Cohen will discuss the opportunity to set up additional joint ventures in other countries using the U.A.E. arrangement as a model.

The recent contract calls for the joint venture partner to invest $5 million on or before September 10, 2010 in a Joint Venture company, XGEN Medical LLC. (”XGen”), a Nevis Island limited liability company.

For additional details about the joint venture agreement, please refer to the August 17, 2010 press release.

“Proteonomix has made great strides recently,” stated Mr. Cohen, “and we have been contacted by several European entities that have requested additional information about our proprietary stem cell activities. In recognition of the interest in Europe and the potential for additional joint venture agreements in various European countries, we recognize that it is propitious to meet with a number of the European institutional investors both to educate them on the intrinsic value of Proteonomix shares and garner interest in strategic relationships.”

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.’s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD).

http://www.proteonomix.com/

__

UnitedHealth Group to Support Members Affected by Hurricane Earl

UnitedHealth Group (NYSE: UNH) and its family of companies, including UnitedHealthcare, Ovations, AmeriChoice, OptumHealth, Ingenix and Prescription Solutions, is taking immediate action to assist people in North Carolina, Virginia, Maryland, Rhode Island, Massachusetts and Maine, who may be affected by Hurricane Earl.

This includes relief to health plan participants who may be displaced and need to refill prescription medications, and opening a free counseling help line for people coping with the emotional consequences of the hurricane.

UnitedHealth Group is a diversified health and well-being company dedicated to helping people live healthier lives and making health care work better. With headquarters in Minnetonka, Minn., UnitedHealth Group offers a broad spectrum of health benefit programs through UnitedHealthcare, Ovations and AmeriChoice, and health services through Ingenix, OptumHealth and Prescription Solutions. Through its family of businesses, UnitedHealth Group serves more than 75 million people worldwide.

www.unitedhealthgroup.com

__

HealthSpring, Inc. to Present at the Stifel Nicolaus Healthcare Conference

HealthSpring, Inc. (NYSE:HS) today announced that its management will participate in the Stifel Nicolaus Healthcare Conference at the Four Seasons Hotel in Boston on Wednesday, September 15, 2010. HealthSpring’s investor presentation by Herbert A. Fritch, Chairman and Chief Executive Officer, and Karey Witty, Executive Vice President and Chief Financial Officer, is scheduled to begin at 2:05 p.m.

Eastern time that day and will be available to investors via a live audio webcast. A link to the webcast can be found at the investor relations section of the Company’s website, www.healthspring.com, and the event will be available for replay for 30 days using that same link.

HealthSpring is based in Nashville, Tennessee, and is one of the country’s largest Medicare Advantage coordinated care plans. HealthSpring currently owns and operates Medicare Advantage plans in Alabama, Florida, Georgia, Illinois, Mississippi, Tennessee, and Texas and also offers a national stand-alone Medicare prescription drug plan.

www.healthspring.com

__

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB)

____________________

Sign Up for our FREE Daily Stock Newsletter

____________________

DoubleInStocks would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com

__

Investor Information

PROTEONOMIX, INC. (OTC.BB: PROT) is a biotechnology company engaged in the discovery and development of stem cell therapeutic and cosmeceutical products. We are developing pre clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. Our discoveries involve non embryonic stem cell treatments.

We have developed sufficient technology for patent applications including a medium and a scaffolding for enhancing the growth of stem cells, a growth platform for stem cells, a unique cord blood banking cryopreservation bag and cosmetic products utilizing a secreted matrix derived from stem cells. We have developed some of our intellectual property utilizing our management and advisory team in conjunction with third party universities and research centers.

We have concentrated on our cosmeceutical treatments based on our licensed technology which we believe will be our lead revenue product in the market. We have completed the development of our cosmeceutical products and we anticipate sales to begin in 2010.

Proteonomix, Inc. (PROT) Plans European Investor Road Show

-Michael Cohen, Chairman and CEO, to Visit Several European Cities to Discuss Company’s Growth Plan and Future Outlook With Investors

PROTEONOMIX, INC. (OTC.BB:PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced last week that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.

Scheduled for early October, Mr. Cohen will discuss with sophisticated investors the recent contract to establish a joint venture with a group of investors that will establish a new stem cell treatment and research facility in the United Arab Emirates (U.A.E.). In addition, Mr. Cohen will discuss the opportunity to set up additional joint ventures in other countries using the U.A.E. arrangement as a model.

The recent contract calls for the joint venture partner to invest $5 million on or before September 10, 2010 in a Joint Venture company, XGEN Medical LLC. (”XGen”), a Nevis Island limited liability company.

For additional details about the joint venture agreement, please refer to the August 17, 2010 press release.

“Proteonomix has made great strides recently,” stated Mr. Cohen, “and we have been contacted by several European entities that have requested additional information about our proprietary stem cell activities. In recognition of the interest in Europe and the potential for additional joint venture agreements in various European countries, we recognize that it is propitious to meet with a number of the European institutional investors both to educate them on the intrinsic value of Proteonomix shares and garner interest in strategic relationships.”

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.’s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD).

http://www.proteonomix.com/

__

MusclePharm Announces MuscleGel Achieves NSF Certification

MusclePharm® Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, today announced MuscleGel achieves NSF certification. In addition, the Company’s Recon and Assault nutritional products will be NSF certified within the coming months.

“We are extremely pleased MusclePharm’s MuscleGel is now NSF certified and look forward to Recon and Assault’s future addition to the NSF’s list of approved supplements,” commented Brad Pyatt, MusclePharm’s Chief Executive Officer. “Our Chief Medical Researcher, Dr. Jeffery Stout, Ph.D. and his team of scientists, doctors, and top professional athletes were instrumental in achieving the NSF’s certification of MuscleGel, Recon and Assault. These three products provide strong, unique opportunities for us to expand MusclePharm’s distribution within the professional athletic community, including the MLB and NFL.”

NSF International is an independent, not-for-profit organization that meets the growing demands of athletes, coaches and all those concerned about banned substances in sports supplements. NSF International created the new NSF Certified for Sport™ Program. This new NSF program is a focused solution designed to minimize the risk that a dietary supplement or sports nutrition product contains banned substances. This program is part of NSF’s successful 60-year history of providing certification programs for food, water and consumer goods.

MLB, the MLB Player’s Association, NFL, the NFL Player’s Association, PGA, LPGA and the CCES have all chosen NSF’s Certified for Sport™ program to help verify the products their athletes use are safer and free of banned substances. NSF GMP for Sport™ certification verifies that the facility, operations and ingredient sourcing are in compliance with GMP requirements via ongoing audits.

MusclePharm products are currently available in 1,200 of the top General Nutrition Centers (GNC) in the United States, as well as Vitamin Shop. MusclePharm’s award-winning products — Assault®, Battle Fuel®, Bullet Proof®, Combat Powder®, Recon® and Shred Matrix®—are also available online at gnc.com, bodybuilding.com, amazon.com and many other locations.

MusclePharm’s top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside™. Headquartered in Aurora, Colorado, the company is a fast-growing developer and manufacturer of safe, scientifically approved, nutritional supplements that are free of banned substances and tested by athletes.

They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists.

www.musclepharm.com

__

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations.Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB). Crown Equity Holdings Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading share from a third party (Swiss Financial Report)  for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB).

____________________

Sign Up for our FREE Daily Stock Newsletter

____________________

DoubleInStocks would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com

__

More Research Needed with Use of Stem Cells

PROTEONOMIX, INC. (PROT.OB), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, applauds the actions taken by the Costa Rican Ministry of Health to hunt down and eliminate unauthorized stem cell clinics. The chief of the ministry’s research council, Dr. Ileana Herrera, stated, “If (stem cell treatment’s) efficacy and safety has not been proven, we don’t believe it should be used.”

Mr. Michael Cohen, Chairman and CEO of Proteonomix, stated, “We have no doubt that stem cell therapies will be a major factor in combatting a variety of medical conditions but it is essential that it be undertaken only after the clinical results determine that such a course of action is efficacious. Too much hype about cures for all types of diseases is diminishing the potential value of stem cells and could unduly delay future progress in stem cell treatments and research. Medical tourism is not a dirty word, if established in an ethical and professional manner.”

Cohen added, “At Proteonomix we have adopted a rigorous and cautious approach that will ensure that patients that are ultimately treated by us have confidence that the procedures will be safe, relatively low cost and offering the best chance for alleviating their specific medical condition. Our research progress has been dramatic and the procedures and intellectual property portfolio, made up of a significant number of pending patents, have resulted in Proteonomix emerging as a leader in the development of stem cell medical treatments.” “The mission of one of our subsidiaries, Proteonomix Regenerative Translational Medicine Institute, Inc. (’PRTMI’), is to translate the most promising internal and external stem cell biology and cellular therapy to clinical applications of regenerative medicine.

PRTMI will undertake the creation of a global, single standard, cellular laboratory that will seek to create a seamless transition between laboratories and patient care facilities.” Mr. Cohen concluded, “We view joint ventures with appropriate strategic partners as a key to the success of Proteonomix and, at the appropriate time, anticipate that PRTMI will engage in such discussions.”

Proteonomix, Inc., a biotechnology company, engages in the development of stem cell therapies primarily for the treatment of diabetes and cardiac therapy, as well as offers cosmeceutical products. The stem cell therapy involves the introduction of healthy new stem cells to repair and replace damaged or lost cells. It offers product for the treatment of anti-aging and damaged skin. The company develops cosmetic products using its technologies, Secreted Matrix and Matrix NC-138 that is a stem cell derived proteins technology.

It also involves in the operation of retail Web site, Proteoderm.com to sell its anti-aging line of skin care products; develops therapeutic modalities for the treatment of cardiovascular disease; and engages in the reproductive tissue banking, including sperm, ova, ovarian tissue, and testicular tissue. In addition, the company develops intellectual properties for patent applications, including a medium and scaffolding for enhancing the growth of stem cells, a growth platform for stem cells, a cord blood banking cryopreservation bag, and a device to eliminate malformed stem cells via filtration.

Further, it is developing pre-clinical-stage therapeutic agents and treatments for cancer, diabetes, heart, lung, and kidney diseases, as well as for stem cell bone marrow and organ transplants. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix was founded in 2005 and is based in Mountainside, New Jersey.

http://www.proteonomix.com/

__

China Sky One Medical Updates Financial Guidance for 2010

China Sky One Medical, Inc. (”China Sky One Medical” or “the Company”) (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People’s Republic of China (”PRC”), today announced that its fiscal year 2010 revenue and adjusted net income, excluding the impact of derivative warrant liabilities, are expected to be lower than its previous financial guidance as a result of the termination of several major distributor relationships.

Specifically, the Company has lowered its 2010 revenue guidance from a prior range of $160 million and $164 million to between $128 million and $136 million. The Company also has lowered its 2010 adjusted net income guidance, excluding the impact of derivative warrant liabilities, from between $40 million and $41 million to between $26 million and $31 million.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company (”TDR”), Harbin First Bio-Engineering Company Limited (”First”), Heilongjiang Tianlong Pharmaceutical, Inc. (”Tianlong”) and Peng Lai Jin Chuang Pharmaceutical Company (”Jin Chuang”) the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source.

http://www.cski.com.cn

__

Codexis, Inc. (Nasdaq:CDXS), a clean technology company, recently announced financial results for the second quarter ended June 30, 2010. For the second quarter of 2010, the company reported revenue of $24.5 million, an increase of 28% from $19.2 million in the second quarter of 2009. Product revenue of $8.5 million increased 102% over the same time period.

Codexis, Inc. develops industrial biocatalysts, enzymes, and microbes for energy, pharmaceutical, and environmental industries. The company focuses on conversion of renewable resources into transportation fuels and pharmaceuticals.

It offers development of technologies for air and water treatment and chemical manufacturing. The companys products include biocatalyst panels, custom biocatalysts, enzymes, active pharmaceutical ingredients and intermediates, and human cytochrome biocatalysts. Codexis was incorporated in 2002 and is based in Redwood City, California with additional offices in Budapest, Hungary; Singapore; and Bangalore, India.

http://www.codexis.com

__

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB)

____________________

Sign Up for our FREE Daily Stock Newsletter

____________________

DoubleInStocks would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com

__

EQ Labs, Inc. (PINK: EQLB)

What is EQ?

EQ is instant energy in any beverage, consisting of a blend of essential vitamins, Gingko Biloba and caffeine keeps you going any time, day or night. EQ is all about energy and living the All-American Lifestyle.

EQ is a great addition to your favorite beverage and mixable to your taste. Drop an EQ into water or any drink (alcoholic or non-alcoholic).

Essentially, one can place a tablet or tube of this product in their pocket or purse and immediately have an energy drink available in the short amount of time that it takes for the tablet to dissolve. Try carrying around six cans or bottles of energy drinks and you will see why EQ Labs encourages consumers to “Think Outside the Can.”

EQ Labs Inc Products

About EQ Labs, Inc.

EQ Labs is engaged in the development, marketing and sale of EQ (”The Smart Energy Drink”). EQ is an effervescent tablet that can be dissolved in any beverage to provide instant energy. Consisting of a blend of essential vitamins, Gingko Biloba, and less caffeine than a cup of coffee. EQ is currently sold at Best Buy, 7-Eleven, Walgreens and other leading retailers.

http://www.drinkeq.com/

__

Jamba Juice Launches ‘Sip to Support(TM)’ 10% Give Back Program as Part of Jamba’s Commitment to Building Healthy Communities

At Jamba Juice (NASDAQ: JMBA), nothing feels quite as good as helping out the community. That’s why the Company announced today it is making support for schools and community organizations easy, fun and healthy by launching Sip to Support – a 10% give back swipe card fundraising program – as part of Jamba’s commitment to building healthy communities.

Jamba healthy communities priorities focus on supporting education, wellness, nutrition and fitness by inspiring healthier schools, neighborhoods and activities; and demonstrate the Company’s commitment to taking the spirit of feeling good and turning it into something meaningful where it matters most and can have the greatest impact for good.

“This is an exciting program and an important part of Jamba’s larger commitment to supporting healthier communities,” said James D. White, chairman, president, and CEO, Jamba Juice Company. “Through our innovative giving back programs and push for more active lifestyles, coupled with our better-for-you portfolio of great tasting product offerings, Jamba Juice is providing our customers the ability to feel good about every purchase they make.”

Jamba, Inc. is a holding company and through its wholly-owned subsidiary, Jamba Juice Company, owns and franchises JAMBA JUICE® stores. Founded in 1990, Jamba Juice is a leading restaurant retailer of better-for-you food and beverage offerings, including great tasting fruit smoothies, juices, and teas, hot oatmeal with organic steel cut oats, wraps, salads, sandwiches, and California Flatbreads™, and a variety of baked goods and snacks.

www.jambajuice.com

__

Converted Organics Inc. (Nasdaq:COIN) announced that it has not received enough votes on the proposal to acquire TerraSphere Systems LLC to constitute a quorum and as such, has postponed its Special Meeting of Shareholders that had been scheduled for August 31, 2010.

COIN has rescheduled the Special Meeting for Thursday, September, 16, 2010 at 9:30 AM. For the Special Meeting to be duly convened, a quorum of voters must be reached. To reach a quorum, a majority of stock issued and outstanding as of the date of record must vote.

Converted Organics is dedicated to producing high-quality, all-natural, organic soil amendment and fertilizer products through food waste recycling. The Company uses its proprietary High Temperature Liquid Composting system, a proven, state-of-the-art microbial digestion technology, to process various biodegradable food wastes into dry pellet and liquid concentrate organic fertilizers that help grow healthier food and improve environmental quality. Converted Organics sells and distributes its environmentally-friendly fertilizer products in the retail, professional turf management, and agribusiness markets.

http://www.convertedorganics.com/

__

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings, Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received fifteen thousand dollars in cash from a third party (EEA, Inc ) for (7) days of advertising for EQ Labs, Inc. (EQLB.PK)

____________________

Sign Up for our FREE Daily Stock Newsletter

____________________

DoubleInStocks would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com

__

Kore Nutrition Incorporated (OTCBB:KORE) and the Company’s wholly owned subsidiary, Go All In, Inc. (”ALL IN”), are pleased to announce the establishment of their new Asian Licensee, ALL IN Asia.

ALL IN Asia is headed by Mr. Desmond Liew, an experienced and highly capable marketing and distribution expert in Asia. ALL IN Asia will manage the rollout of ALL IN Energy products throughout the important markets of Mainland China, Hong Kong, and Korea initially, then expand distribution throughout the rest of this region over time.

The Asia Pacific region accounts for an estimated 30% of worldwide energy drink consumption. According to Zenith International, the worldwide beverage consumption analytical firm, annual beverage consumption growth projections through 2010 in Asia will be, on average, 12% - 14%, and projected to continue at this level through 2015.

ALL IN Energy products will be custom designed to appeal to Asian consumers across all demographics but with special consideration towards an increasingly prevalent poker and casino culture. Consumers in this market are expected to immediately identify with ALL IN’s brand focus of safely providing a sustained level of energy, focus, stamina, sharpness of mind and memory, and immune system support, during times of extreme competitive pressure, as well as for the everyday demands of life.

Legendary poker champion Johnny Chan has joined together with fellow top poker professionals, who all endorse ALL IN(TM) Energy drinks.

Kore, through its wholly-owned subsidiary, ALL IN, is engaged in the business of developing, producing, and selling non-alcoholic beverages. It produces premium energy drinks and an enhanced purified water under the brand name, ALL IN(TM) Energy, to suit the demands of an active world.

www.allinenergy.com

__

PepsiCo’s (NYSE:PEP) Gatorade line of performance drinks adds over 40 years of rehydration and sports nutrition research.

In 2010, Gatorade introduced the G Series; a new line of products from Gatorade that go beyond hydration to provide fuel, fluid and nutrients before, during and after the game.

Gatorade Prime 01: Pre-game fuel in a convenient 4-oz. pouch, designed to be used in the 15 minutes before the game to provide energy by maximizing the availability of carbohydrate energy to muscles.

Gatorade Perform 02: The proven Gatorade Thirst Quencher that offers a scientifically-formulated blend of carbohydrates and key electrolytes, and is designed for use during the game to help athletes rehydrate, replenish electrolytes and refuel with carbohydrate to push through all four quarters.

G2 Perform 02: A low-calorie sports drink that delivers functional hydration to athletes during the game, but with less than half the calories of Gatorade Thirst Quencher.

Gatorade Recover 03: The first protein recovery beverage with the consistency of a thirst quencher. Recover 03 is formulated for use immediately after the game (within 30-60 minutes) for rehydration and to promote muscle recovery.

http://www.pepsico.com

__

Professional Research on Dean Foods and Mead Johnson Nutrition Company - Food Processing Industry Starving in the U.S.

www.wallstreetequityresearch.com allows shareholders to gain full understanding of the economic and market forces influencing the food processing industry, and offers free research on industry players Dean Foods Co. (NYSE: DF) and Mead Johnson Nutrition Company (NYSE: MJN).

High unemployment and economic turbulence in the western world is continuing to take its toll on companies in the food processing industry. While companies with worldwide distribution opportunities are able to gain revenue from emerging markets, those limited to the US and Europe are still being effected by frugal consumer habits.

High levels of discounting and promotion are continuing to plague the market which is struggling to move higher priced brands consistently. Although there has been some increase in demand for higher priced luxury items as the upper-income consumers gain confidence, uncertainty about employment benefits during June and July has decreased lower-income spending.

Companies offering child and infant nutrition are suffering in the U.S. due to low birth rates as well as recession driven changes in consumption. However, emerging markets are proving profitable especially in China. With recent scandals regarding the safety of Chinese products buyers are now increasingly reaching for the safety of international brands.

In the recent earnings season, Dean Foods Co., the U.S. largest dairy producer, saw its profits declined to $44.8 million from $62.3 million a year back on revenue of $2.95 billion. On the other hand, Mead Johnson Nutrition Company earnings also experience a dive to $121.4 million.

http://www.mjn.com

__

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings, Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received seven thousand five hundred dollars from a third party (Alan Jones Group) for one (1) day of advertising for KORE Nutrition, Inc.(OTC BB: KORE.OB)

____________________

Sign Up for our FREE Daily Stock Newsletter

____________________

DoubleInStocks would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com